Category: Zacks Small Cap Research

1234512830 / 1280 POSTS
By John Vandermosten, CFA NASDAQ:ACHV READ THE FULL ACHV RESEARCH REPORT Achieve Life Sciences, Inc. (NASDAQ:ACHV) has experienced a considerable of activity since our first quarter update published several weeks ago. We saw a $23 million capital rai ...
By John Vandermosten, CFA NASDAQ:TLSA | LSE:TILS READ THE FULL TLSA RESEARCH REPORT Since our last update at the end of May, Tiziana Life Sciences PLC (NASDAQ:TLSA) (LSE:TILS) has been busy with multiple activities. The company announced its virtual ...
By M. Marin NYSE:CXW READ THE FULL CXW RESEARCH REPORT Asset Divestitures Advance Balance Sheet Objectives CoreCivic (NYSE:CXW) announced yesterday that it has completed the divestiture of non-core assets that it discussed earlier in the quarter. CX ...
By David Bautz, PhD OTC:APLIF | TSX:APLI.TO READ THE FULL RESEARCH REPORT Business Update DSMB Recommends PRESECO Trial Continue Without Modification; Data in 3Q21 In May 2021, Appili Therapeutics, Inc. (OTC:APLIF) (TSX:APLI.TO) announced that the in ...
By David Bautz, PhD NASDAQ:MDNA READ THE FULL MDNA RESEARCH REPORT Business Update CTA Submitted, Phase 1/2 Clinical Trial of MDNA11 to Start in 3Q21 On June 23, 2021, Medicenna Therapeutics Corp. (NASDAQ:MDNA) announced it has submitted a Clinical T ...
By Lisa Thompson NASDAQ:TSEM READ THE FULL TSEM RESEARCH REPORT Today Tower (NASDAQ:TSEM) announced it had struck a deal with STMicroelectronics (NYSE:STM) to utilize a third of ST’s Agrate R3 fab now under construction in Agrate Brianza, Italy. It i ...
By John Vandermosten, CFA TSX:HBP.TO | OTC:HBPCF READ THE FULL HBP.TO RESEARCH REPORT Helix BioPharma Corp. (TSX:HBP.TO) (OTC:HBPCF) reported 3Q:21 financial and operational results and submitted its SEDAR filings on June 14, 2021. During 3Q:21, the ...
By John Vandermosten, CFA CNSX:ORTH.CN | OTC:ORTIF READ THE FULL ORTH.CN RESEARCH REPORT Changes to the Board Ortho Regenerative Technologies Inc. (CSE:ORTH.CN) (OTC:ORTIF) announced the addition of two new board members in a June 15th release. The n ...
By M. Marin NASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT Advantages include expansion of the pool of potential investors & increased awareness of the company’s growth strategy Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) shares are to be included ...
By David Bautz, PhD NASDAQ:MNOV READ THE FULL MNOV RESEARCH REPORT Business Update Positive Results for MN-166 in Phase 2 AUD Trial On June 21, 2021, MediciNova, Inc. (NASDAQ:MNOV) announced that positive results from a Phase 2 trial of MN-166 (ibudi ...
1234512830 / 1280 POSTS